Richard Steinhart - 28 Dec 2023 Form 4 Insider Report for Actinium Pharmaceuticals, Inc. (ATNM)

Role
Director
Signature
/s/ Richard Steinhart
Issuer symbol
ATNM
Transactions as of
28 Dec 2023
Net transactions value
$0
Form type
4
Filing time
29 Dec 2023, 17:23:38 UTC
Previous filing
18 Dec 2023
Next filing
08 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATNM Stock Option (Right to Buy) Award $0 +70,311 $0.000000 70,311 28 Dec 2023 Common Stock 70,311 $5.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This price represents the closing price of the Issuer's common stock on December 28, 2023, the date of the grant.
F2 Pursuant to the terms of the Issuer's 2019 Stock Plan, 2% of the options will vest each month from the date of grant until fully vested.